UMG Lenti: Novel Lentiviral Vectors for Efficient Transgene- and Reporter Gene Expression in Human Early Hematopoietic Progenitors
UMG Lenti: новые лентивирусные векторы для эффективной экспрессии трансгена и репортерного гена в ранних гемопоэтических клетках-предшественниках человека
2014-12-12
SCID: 54.1/5h75ac2z
Discuss with AI
EGFP reporterUBC promoterdual-promoter vectorshematopoietic stem and progenitor cellslentiviral vectors
Figures from the paper
Abstract (AI)
Lentiviral vectors are widely used to investigate the biological properties of regulatory proteins and/or of leukaemia-associated oncogenes by stably enforcing their expression in hematopoietic stem and progenitor cells. In these studies it is critical to be able to monitor and/or sort the infected cells, typically via fluorescent proteins encoded by the modified viral genome. The most popular strategy to ensure co-expression of transgene and reporter gene is to insert between these cDNAs an IRES element, thus generating bi-cistronic mRNAs whose transcription is driven by a single promoter. However, while the product of the gene located upstream of the IRES is generally abundantly expressed, the translation of the downstream cDNA (typically encoding the reporter protein) is often inconsistent, which hinders the detection and the isolation of transduced cells. To overcome these limitations, we developed novel lentiviral dual-promoter vectors (named UMG-LV5 and -LV6) where transgene expression is driven by the potent UBC promoter and that of the reporter protein, EGFP, by the minimal regulatory element of the WASP gene. These vectors, harboring two distinct transgenes, were tested in a variety of human haematopoietic cell lines as well as in primary human CD34+ cells in comparison with the FUIGW vector that contains the expression cassette UBC-transgene-IRES-EGFP. In these experiments both UMG-LV5 and UMG-LV6 yielded moderately lower transgene expression than FUIGW, but dramatically higher levels of EGFP, thereby allowing the easy distinction between transduced and non-transduced cells. An additional construct was produced, in which the cDNA encoding the reporter protein is upstream, and the transgene downstream of the IRES sequence. This vector, named UMG-LV11, proved able to promote abundant expression of both transgene product and EGFP in all cells tested. The UMG-LVs represent therefore useful vectors for gene transfer-based studies in hematopoietic stem and progenitor cells, as well as in non-hematopoietic cells.
Key Findings
1
In human hematopoietic cell lines and primary CD34+ cells, UMG-LV5 and UMG-LV6 produced moderately lower transgene expression than FUIGW but dramatically higher EGFP levels.
2
The UMG-LV vectors provide useful tools for gene-transfer studies in human hematopoietic stem and progenitor cells.
3
The enhanced EGFP expression from UMG-LV5 and UMG-LV6 enabled easier discrimination between transduced and non-transduced hematopoietic cells.
4
The study developed dual-promoter lentiviral vectors UMG-LV5 and UMG-LV6, using UBC for transgene expression and a minimal WASP regulatory element for EGFP expression.
5
UMG-LV11, placing EGFP upstream and the transgene downstream of an IRES, supported abundant expression of both reporter and transgene products across all tested cells.
Research Object
Novel lentiviral dual-promoter vectors (UMG-LV5, UMG-LV6, and UMG-LV11) used in human hematopoietic cell lines and primary human CD34+ hematopoietic progenitor cells
Research Subject
Efficiency and consistency of co-expression of transgenes and the EGFP reporter, including comparative expression performance of the UMG-LVs versus the FUIGW IRES-based vector
Publication Details
Publication Date
2014-12-12
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest